In breast cancer cells, inhibition of autophagy by 3-MA or beclin-1 siRNA potentiated the resensitization of previously antiestrogen resistant breast cancer cells [6, 14], suggesting a pro-survival role of autophagy in anti-estrogen therapy. This evidence concerns the gene BECN1 and breast carcinoma.